Specialty Pharmacy

Efforts to reduce injection frequency can have positive health benefits with or without HIV infection, study suggests.

Increased development of biosimilars will drive the need for analytical instrument analyzers, report finds.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses how specialty pharmacies can help patients gain access to costly specialty drug regimens.

Increased expression of EGFR-positive myeloid cells associated with tumor progression and reduced survival in bowel cancer.

Top news of the day from across the health care landscape.

Monoclonal antibody drugs may soon be an effective preventative treatment for chronic migraines.

The FDA has issued 14 warning letters and 4 online advisory letters to US-based companies illegally selling more than 65 products with fraudulent claims that they cure cancer.

Various health reform approaches may affect each pharmaceutical manufacturer differently.

Pharmacists and pharmacies have become key players in improving patient outcomes.

Redox active iron molecules react with vitamin C and increase cancer cell vulnerability.

The largest conference in the specialty pharmacy industry will return to Wynn/Encore Las Vegas on April 30, 2017.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.

Study finds drug prices have been both increasing and decreasing for prescription drugs, independent of rebates.

Auranofin is a gold-containing drug used to alleviate the symptoms of rheumatoid arthritis.

Top news of the day from across the health care landscape.

Relationship between MS and common herpes virus Epstein-Barr virus offer new treatment target.

While the job of the FDA is to protect the public from ineffective drugs, patients in need of life-saving treatments push for accelerated approval of specialty drugs.

Drug combination increases the efforts of killing cancer cells.

Predicting the evolution of HIV surface proteins could be used to develop better vaccines.

Final data demonstrates the meaningful impact nusinersen can have on children with later-onset spinal muscular atrophy.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.

Top news of the day from across the health care landscape.

Litigation to continue surrounding biological mechanisms of dupilumab (Dupixent).

Top news of the week in oncology and cancer drug development.

Tool could improve detection of cancer, bacterial and viral infections.

Renflexis approved to treat multiple conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis.

Real world observational study supports data on sustained hepatitis C virologic response rates.

Early detection found to improve survival in bowel cancer.